文献速递其他结缔组织病

同伴主导的症状管理干预提升系统性硬化症患者心理韧性:一项随机临床试验的中介分析

Peer-Led Symptom Management Intervention to Enhance Resilience in People With Systemic Sclerosis: Mediation Analysis From a Randomized Clinical Trial.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2024-05-31

本研究为随机对照试验的二次数据分析,纳入173例系统性硬化症患者,比较12周在线同伴健康辅导干预与等待名单对照。干预组心理韧性改善(P < 0.001),且韧性变化中介了干预对疲劳、疼痛干扰和抑郁症状的改善效应。

要点

  • 干预组心理韧性较对照组改善(P < 0.001)。
  • 韧性变化中介疲劳改善,间接效应-1.41(95%CI -2.41至-0.41)。
  • 韧性变化中介疼痛干扰(-0.86,95%CI -1.65至-0.08)和抑郁症状(-1.99,95%CI -3.16至-0.81)改善。

核心结论

  • 在干预组中,躯体与心理症状获得积极改善的参与者,心理韧性增加是这些改善的机制。
  • 这些发现支持在类似系统性硬化症干预中关注心理韧性以改善症状的重要性。

研究设计与样本

  • 本研究为随机对照试验的二次数据分析,比较同伴健康辅导干预与等待名单对照。
  • 共纳入173例符合条件的系统性硬化症患者,干预为期12周、在线进行。
  • 参与者在基线、第6周和第12周完成康纳-戴维森心理韧性量表、慢性病治疗功能评估-疲劳量表以及患者报告结局测量信息系统疼痛干扰和抑郁症状测量。
  • 采用线性混合效应回归模型评估干预对心理韧性变化的影响,并进行因果中介分析检验第12周韧性变化是否中介干预对第12周疲劳、疼痛干扰和抑郁症状变化的影响。

主要发现

  • 干预组报告心理韧性改善(P < 0.001)。
  • 心理韧性变化中介了干预对疲劳的效应,间接效应为-1.41(95%CI -2.41至-0.41)。
  • 心理韧性变化中介了干预对疼痛干扰的效应,间接效应为-0.86(95%CI -1.65至-0.08)。
  • 心理韧性变化中介了干预对抑郁症状的效应,间接效应为-1.99(95%CI -3.16至-0.81)。

临床怎么用

  • 原文结论指出,这些发现支持在类似系统性硬化症干预中关注心理韧性以改善症状的重要性(作者认为)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Facilitated self-management interventions have the potential to enhance resilience and well-being. We examined whether resilience is a mediator of improving physical and psychological symptoms for people with systemic sclerosis (SSc) who participated in a 12-week online peer-led symptom management intervention. METHODS: We conducted a secondary data analysis from a randomized control trial comparing a peer health-coached intervention to a waitlist control. Participants completed the Connor-Davidson Resilience Scale, the Functional Assessment of Chronic Illness Therapy-Fatigue scale, and the Patient Reported Outcomes Measurement Information System measures of pain interference and depressive symptoms at the baseline and at weeks 6 and 12. Linear mixed effect regression models were used to assess the effect of intervention on changes in resilience. Causal mediation analyses were conducted to examine whether changes in resilience at week 12 mediated intervention effects on changes in fatigue, pain interference, and depressive symptoms at week 12. RESULTS: One hundred and seventy-three eligible participants were enrolled. Participants in the intervention group reported improvements in resilience (P < 0.001). These changes in resilience mediated the intervention effects on fatigue with indirect effect of -1.41 (95% confidence interval [CI] -2.41 to -0.41), pain interference of -0.86 (95% CI -1.65 to -0.08), and depressive symptoms of -1.99 (95% CI -3.16 to -0.81). CONCLUSION: For participants in the intervention who had positive improvements in their physical and psychological symptoms, increased resilience was a mechanism for these improvements. These findings support the importance of addressing resilience to improve symptoms in similar SSc interventions.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Chen YT, Hassett AL, Huang S, et al. Peer-Led Symptom Management Intervention to Enhance Resilience in People With Systemic Sclerosis: Mediation Analysis From a Randomized Clinical Trial. Arthritis Care Res (Hoboken). 2024. PMID: 38622109. doi:10.1002/acr.25352

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。